Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Lagrange (Umeå, Sweden), U. Nilsson (Umeå, Sweden), C. Stridsman (Umeå, Sweden), H. Backman (Umeå, Sweden), L. Hedman (Umeå, Sweden), A. Lindberg (Umeå, Sweden), A. Blomberg (Umeå, Sweden). hsCRP is associated with 10-year mortality in COPD.. 2075

Member's Comments

No comment yet.

Related content which might interest you: Triglycerides are associated with five-year mortality in COPD patients Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 No impact of statins on time to first COPD exacerbation or all-cause mortality Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Copeptin predicts all-cause mortality in stable COPD: An analysis of the COSYCONET study Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008 COPD the unseen factor causing increased morbidity and mortality among IHD patients Source: Annual Congress 2009 - COPD case-finding and management in primary care Year: 2009 Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019 Year: 2019 Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis. Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD Source: Eur Respir J 2016; 47:1365-1373 Year: 2016 COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Risk charts of five-year mortality in COPD patients Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality Source: International Congress 2015 – COPD: interesting notes Year: 2015 Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 Tiotropium and the risk of cardiovascular events and all-cause mortality Source: Annual Congress 2010 - Comorbidities and disease management in primary care Year: 2010 Changes in physical activity and all-cause mortality in COPD Source: Eur Respir J 2014; 44: 1199-1209 Year: 2014 Predictors of mortality in COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Predictors of mortality in COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 10-year follow-up of hospitalised COPD-patients: Comorbidities, mortality and cause of death Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018